Eris Lifesciences completed the acquisition of a 70% stake in Swiss Parenterals for $105m.

Synopsis

Eris Lifesciences, an Indian branded formulations company, completed the acquisition of a 70% stake in Swiss Parenterals, a progressing dynamic pharmaceutical manufacturing company, for $105m.

Principals

target

Swiss Parenterals

bidder

Eris Lifesciences

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

cyril amarchand mangaldas

HQ - Mumbai

legal advisors

target

252

Deals

£ 157.43 B

Total Value